Dr. Andrew S. Taussig

• 
  www.orlandosentinel.com/news/science/orl-stemcell2508ma - [Cached Version]
  Published on: 5/25/2008    Last Visited: 5/25/2008  

  "What we're trying to do is take the body's own repair kit, these premature cells that we all have, and allow them to develop into new heart muscle," said Dr. Andrew Taussig, president of the Florida Heart Institute at Florida Hospital.
  ...
  If the concept works, Taussig said it could "revolutionize" the treatment of heart disease.
  ...
  Taussig said they need to have severe congestive heart disease, falling into what doctors call "class 3" or "class 4" heart failure.
  ...
  "We have to be cautiously optimistic," said Taussig.

• 
  orlando.bizjournals.com/orlando/stories/2007/04/23/stor - [Cached Version]
  Published on: 4/20/2007    Last Visited: 4/21/2007  

  American Heart Association, Baxter Healthcare Corp., Florida Hospital, Harley-Davidson, U.S. Centers for Disease Control and Prevention, University of Central Florida, Kiminobu Sugaya, Andrew Taussig,
  ...
  "It's cutting-edge clinical research, and it's important that the hospital participates in these kind of trials to keep it at the forefront of technology," says Dr. Andrew Taussig, cardiologist and principle investigator for the trial at Florida Hospital.
  ...
  "The hope is that the patient's own stem cells will stimulate growth of new blood vessels and circulation in the heart," says Taussig.
  
  However, like most clinical trials, this procedure is not for everyone.In fact, it involves a monthlong screening process for patients wanting to participate.
  
  Those who are able to undergo conventional procedures such as angioplasty, stents or coronary artery bypass surgery to improve blood flow to the heart are not eligible for the study."This trial offers a possible treatment for patients who have exhausted all other treatment options and still do not have an acceptable quality of life," says Taussig.
  
  He adds that the research also is promising on a large scale, because if it proves to regenerate vessels, it could lead to treating patients with their own stem cells in conjunction with other treatments.
  
  Contact the Editor Need Assistance?More Latest News

• 
  www.orlandomagazine.com/archives?view=article&id=1196 - [Cached Version]
  Published on: 12/1/2008    Last Visited: 1/16/2009  

  Andrew S. Taussig1745 North Mills Avenue Orlando 407-841-7151

• 
  www.flheart.org/medprof/pers/taussig.htm - [Cached Version]
  Published on: 8/25/2007    Last Visited: 6/16/2004  

  Andrew S. Taussig, MD
  
  kevin D. Accola, MD
  ...
  Andrew S. Taussig, MDVice PresidentCentral Florida Cardiology Group500 E. Colonial DriveOrlando, FL 32803Phone: 407.841.7151Fax: 407.872.1336
  
  Dr. Andrew S. Taussig, born in New York City, obtained his Bachelor of Science in Biology with honors at Trinity College in Hartford, Connecticut.He attended Emory University School of Medicine for his MD.He served as Chief Medical Resident and cardiac fellow to the renowned J. Willis Hurst, M.D., later joining the cardiology faculty at Emory and becoming a colleague of Dr. Andreas Gruentzig, the inventor of coronary angioplasty.He is a Clinical Assistant Professor of Medicine at the University of Florida School of Medicine.Dr. Taussig is conducting ongoing research in the field of coronary angioplasty.He is a Diplomate of the American Board of Internal Medicine and Cardiovascular Diseases, a fellow of the Society of Cardiac Angiography, and a fellow of the American College of Cardiology.He is a former Co-Director of the cardiac catherization laboratory and former Chairman of the Department of Cardiology at Florida Hospital.

• 
  orlando.bizjournals.com/orlando/stories/2007/04/23/stor - [Cached Version]
  Published on: 4/20/2007    Last Visited: 4/21/2007  

  Florida Hospital, Harley-Davidson, Baxter Healthcare Corp., American Heart Association, U.S. Centers for Disease Control and Prevention, University of Central Florida, Kiminobu Sugaya, Andrew Taussig,
  ...
  "It's cutting-edge clinical research, and it's important that the hospital participates in these kind of trials to keep it at the forefront of technology," says Dr. Andrew Taussig, cardiologist and principle investigator for the trial at Florida Hospital.
  ...
  "The hope is that the patient's own stem cells will stimulate growth of new blood vessels and circulation in the heart," says Taussig.
  
  However, like most clinical trials, this procedure is not for everyone.In fact, it involves a monthlong screening process for patients wanting to participate.
  
  Those who are able to undergo conventional procedures such as angioplasty, stents or coronary artery bypass surgery to improve blood flow to the heart are not eligible for the study."This trial offers a possible treatment for patients who have exhausted all other treatment options and still do not have an acceptable quality of life," says Taussig.
  
  He adds that the research also is promising on a large scale, because if it proves to regenerate vessels, it could lead to treating patients with their own stem cells in conjunction with other treatments.
  
  Contact the Editor Need Assistance?More Latest News

• 
  www.celebrationindependent.com/Pages/4.15.07.pages/pati - [Cached Version]
  Published on: 4/15/2007    Last Visited: 6/30/2007  

  "This trial offers a possible treatment for patients who have exhausted all other treatment options and still do not have an acceptable quality of life," said Andrew Taussig, MD, cardiologist and principal investigator for the trial at Florida Hospital.

• 
  www.flheart.org/find-physician - [Cached Version]
  Last Visited: 8/16/2009  

  Andrew Taussig, MD

• 
  Acc.org - I2 Summit 2006 - Faculty - [Cached Version]
  Published on: 2/1/2006    Last Visited: 12/7/2007  

  Andrew S. Taussig

• 
  Andrew Taussig, Cardiovascular Physician - Florida... - [Cached Version]
  Published on: 5/4/2009    Last Visited: 5/18/2009  

  Andrew S. Taussig, MD American Board of Internal Medicine
  
  1745 N. Mills Ave. Suite 100 Orlando, FL 32803
  
  Phone: (407) 841-7151 Fax: (407) 872-1336
  ...
  Andrew S. Taussig, MD

• 
  CardioVascular BioTherapeutics, Inc. - [Cached Version]
  Last Visited: 8/1/2009  

  Principal Investigator: Dr. Andrew Taussig

Page:  1 2